MOTS-c 10mg by Dragon Pharma
What Is MOTS-c 10mg?
MOTS-c is a mitochondrial-derived peptide, a short signaling molecule encoded in mitochondrial DNA rather than nuclear DNA. It is studied for its role in metabolic regulation: research links it to AMPK activation, improved insulin sensitivity, higher fatty acid oxidation and better exercise capacity.
Dragon Pharma supplies MOTS-c as a 10 mg lyophilized vial for reconstitution with bacteriostatic water. In performance research it is referenced for fat metabolism, training stamina and cellular energy balance, which makes it a popular metabolic peptide for recomp and endurance-oriented protocols.
Each vial contains 10 mg of MOTS-c by Dragon Pharma. MOTS-c is a research peptide with no completed human clinical trials behind it, and it is intended for laboratory research only.
MOTS-c 10mg Research Use
MOTS-c is injected subcutaneously after reconstitution. The most common references describe reconstituting the 10 mg vial with 2 ml of bacteriostatic water for a 5 mg per ml solution, and daily doses in the 5-10 mg range over 4-8 week windows, though some protocols use a lower dose every few days.
| Reference | Detail |
|---|---|
| Reconstitution | 2 ml bacteriostatic water = 5 mg per ml |
| Daily reference | 1-2 ml (5-10 mg) per day, subcutaneous |
| Alternate reference | 5 mg every 5 days is also described in research logs |
| Cycle reference | 4-8 weeks, with breaks between cycles |
- Use only sterile bacteriostatic water for reconstitution
- Rotate injection sites and refrigerate after mixing
- Confirm product purity before use, as quality varies by source
Practical Notes
MOTS-c has not completed human clinical trials, so all of the above are practical research references only and must be validated by the researcher.
MOTS-c Stacks
MOTS-c is a metabolic peptide, so it is usually stacked with other metabolic and endurance-oriented compounds. All rows below link to same-brand Dragon Pharma products.
| Combination | Why it is combined |
|---|---|
| Aicar 50mg | Both act on the AMPK pathway for metabolic and endurance research |
| AOD 9604 5 mg | Pairs a mitochondrial peptide with a lipolysis-focused fragment analog |
| GW 501516 | Adds a PPAR-delta reference for endurance and fatty acid oxidation |
| L-Carnitine 500 | Supports mitochondrial fatty acid transport in recomp blocks |
MOTS-c Side Effects
Because MOTS-c has not been through completed human clinical trials, its full safety profile is unknown. Self-experimenter reports describe mostly mild and transient effects, and injection site reactions are the most predictable complaint.
- Gastrointestinal discomfort, fatigue or headache in some users
- Reports of increased heart rate or palpitations at higher doses
- Injection site redness or irritation
- Purity and sterility risk if the source is not verified
MOTS-c 10mg is a research peptide with an incomplete safety record. It is not approved for human or veterinary use. Reconstitute only with sterile bacteriostatic water and handle under clean conditions.
For research use only. Do not use this page as dosing or medical advice; mitochondrial peptide protocols belong in a qualified laboratory setting.
What is MOTS-c peptide?
MOTS-c is a mitochondrial-derived peptide encoded in mitochondrial DNA. It acts as a metabolic signaling molecule and is studied for effects on AMPK, insulin sensitivity, fatty acid oxidation and exercise capacity.
Where does MOTS-c come from?
MOTS-c is produced naturally from the short open reading frame of the mitochondrial 12S rRNA gene. It is unusual because it comes from mitochondrial DNA rather than the nuclear genome.
What does MOTS-c do?
Research describes MOTS-c as an activator of AMPK, the cellular energy sensor. That places it in studies on metabolic efficiency, glucose handling, fat oxidation and endurance performance.
How do you reconstitute the MOTS-c 10 mg vial?
The 10 mg lyophilized vial is typically mixed with 2 ml of sterile bacteriostatic water, giving a 5 mg per ml concentration. Swirl gently rather than shake, then refrigerate.
What is the typical MOTS-c dosage?
Community research references most often cite 5-10 mg per day injected subcutaneously, with some protocols using 5 mg every 5 days. No clinical standard exists because human trials are incomplete.
Is MOTS-c safe to use?
Long-term safety is unknown because there are no completed human clinical trials. Reported effects are mostly mild, but purity, sterility and dose control are entirely on the researcher and the source.
How long should a MOTS-c cycle last?
Most cited research windows run 4-8 weeks followed by a break. Because long-term data are absent, shorter cycles with clean sourcing are the more conservative choice.
Does MOTS-c help with fat loss?
MOTS-c research shows increased fatty acid oxidation and improved metabolic efficiency in animal models, which is why it is studied for fat loss. Human results are anecdotal and depend on diet and training.
What are the side effects of MOTS-c?
Reported side effects are mild and include gastrointestinal discomfort, fatigue, headache and injection site reactions. Higher doses carry isolated reports of heart rate or palpitation changes.
What is the difference between MOTS-c and SS-31?
Both target mitochondria, but they work differently: MOTS-c is a metabolic signaling peptide tied to AMPK, while SS-31 acts on cardiolipin to support mitochondrial structure and energy production.
Related Products
